Jardy Tablet 25mg

About Jardy Tablet 25mg

Jardy Tablet Uses

• Type 2 diabetes mellitus, alone or combined with other antidiabetic medicines to control blood sugar
• Add-on therapy for adults who need stronger glycemic control than the 10mg dose provides
• A reduction in cardiovascular death risk for adults with type 2 diabetes and known heart disease
• Long-term blood sugar management as part of a broader diabetes care plan

Jardy Tablet Benefits

• A stronger glucose-lowering effect at the higher 25mg strength
• Reduced body weight through calorie loss via urinary glucose excretion
• A modest reduction in systolic blood pressure alongside glucose control
• Convenient once-daily oral dosing with or without food

What Experts Say

Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that reduces blood glucose by limiting its reabsorption in the kidney's proximal tubule. Excess glucose exits through urine instead of returning to circulation, an insulin-independent action that works alongside other diabetes drugs with different mechanisms.

The EMPA-REG OUTCOME trial specifically evaluated the 10mg and 25mg doses together and found consistent cardiovascular mortality reduction across both strengths, giving physicians confidence to titrate patients up to 25mg without losing the drug's protective cardiac effect.

25mg is the maximum approved dose of Empagliflozin and is typically reached after a patient tolerates the 10mg starting dose well but needs additional glycemic control. Physicians check kidney function before escalating the dose, since efficacy declines and risk of volume depletion rises in patients with significantly reduced kidney function.

Drug Class

• Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor
• Antidiabetic Agent
• Oral Hypoglycemic Drug

Jardy Tablet 25mg formula

• Empagliflozin

Available forms

• Tablet

How to use Jardy Tablet 25mg?

• One tablet by mouth once daily, preferably in the morning
• The tablet should be swallowed whole with water, not crushed, split, or chewed
• Food does not affect absorption, so it may be taken with or without meals
• A missed dose should not be doubled up, simply continue with the next scheduled dose

Drug Interactions

• Insulin and Insulin Secretagogues: A higher hypoglycemia risk when combined, especially at the 25mg dose
• Diuretics: A greater risk of volume depletion and low blood pressure
• NSAIDs: A possible reduction in kidney function with regular combined use
• Rifampicin and Other Enzyme Inducers: A possible reduction in Empagliflozin's blood levels and effectiveness

Risks and warnings

• Genital Mycotic Infections: A higher risk than lower doses due to greater glucose excretion in urine
• Volume Depletion: A drop in blood pressure and dizziness, particularly in patients over 65 or those taking diuretics
• Ketoacidosis Risk: Immediate care is needed for nausea, vomiting, or abdominal pain even with normal glucose readings
• Kidney Function: Not recommended once kidney function falls below a certain threshold, baseline and periodic testing are required
• Lower Limb Amputation: A rare risk reported with some SGLT2 inhibitors, foot care should be discussed with a doctor
• Bone Fracture Risk: A possible reduction in bone density with long-term use in some patients

Jardy Tablet Side Effects

• Urinary tract infection
• Genital yeast infection
• Increased thirst and urination
• Dizziness or lightheadedness
• Back pain
• Nausea
• Upper respiratory infection symptoms
• Elevated cholesterol levels

Storage Conditions

• Store below 30°C in a dry place away from heat and sunlight
• Keep tablets sealed in the original blister strip until use
• Avoid exposing the pack to excess moisture or humidity
• Store safely out of reach of children and pets